| Schedule of Revenue by Service Line |
Revenue by Service Line
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
(in thousands) |
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Biologics and drug delivery |
|
|
|
|
|
|
|
|
|
|
|
|
Disposable products |
|
$ |
1,185 |
|
|
$ |
1,292 |
|
|
$ |
4,023 |
|
|
$ |
4,943 |
|
Services and license fees |
|
|
3,710 |
|
|
|
3,110 |
|
|
|
9,711 |
|
|
|
8,889 |
|
Subtotal – Biologics and drug delivery revenue |
|
|
4,895 |
|
|
|
4,402 |
|
|
|
13,734 |
|
|
|
13,832 |
|
Neurosurgery navigation and therapy |
|
|
|
|
|
|
|
|
|
|
|
|
Disposable products |
|
|
5,438 |
|
|
|
3,422 |
|
|
|
16,877 |
|
|
|
10,131 |
|
Subtotal – Neurosurgery navigation and therapy revenue |
|
|
5,438 |
|
|
|
3,422 |
|
|
|
16,877 |
|
|
|
10,131 |
|
Capital equipment and software |
|
|
|
|
|
|
|
|
|
|
|
|
Systems and software products |
|
|
1,268 |
|
|
|
647 |
|
|
|
3,169 |
|
|
|
1,575 |
|
Services |
|
|
474 |
|
|
|
390 |
|
|
|
1,303 |
|
|
|
1,023 |
|
Subtotal – Capital equipment and software revenue |
|
|
1,742 |
|
|
|
1,037 |
|
|
|
4,472 |
|
|
|
2,598 |
|
Total revenue |
|
$ |
12,075 |
|
|
$ |
8,861 |
|
|
$ |
35,083 |
|
|
$ |
26,561 |
|
|
| Schedule of Other Current Assets |
|
|
|
|
|
|
|
|
|
(in thousands) |
|
September 30, 2026 |
|
|
December 31, 2025 |
|
Accounts receivable, net |
|
$ |
8,017 |
|
|
$ |
6,549 |
|
Other contract assets |
|
|
|
|
|
|
Unbilled receivables |
|
$ |
1,062 |
|
|
$ |
714 |
|
Deferred contract costs |
|
$ |
— |
|
|
$ |
150 |
|
|